Smruthi Organics Limited (BOM:540686)

Market Cap	1.51B
Revenue (ttm)	1.26B
Net Income (ttm)	35.63M
Shares Out	11.45M
EPS (ttm)	3.11
PE Ratio	42.28
Forward PE	n/a
Dividend	1.50 (1.17%)
Ex-Dividend Date	Jun 13, 2025

Volume	7,492
Average Volume	4,303
Open	128.35
Previous Close	128.40
Day's Range	127.00 - 134.00
52-Week Range	103.00 - 169.00
Beta	0.18
RSI	56.93
Earnings Date	Jul 25, 2025

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 267
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540686

Financial Performance

In 2024, Smruthi Organics's revenue was 1.26 billion, a decrease of -1.28% compared to the previous year's 1.28 billion. Earnings were 35.63 million, a decrease of -0.76%.